101 STRIDE: phase III study of therapeutic cancer vaccine L-BLP25 with hormonal treatment as first-line therapy for women with hormone receptor-positive, inoperable, locally advanced, recurrent, or metastatic breast cancer
W. Eiermann, D. Miles, T. Gilewski, M. Trudeau, B. Xu, C. Barrios, K. Pendergrass, S.P. Eggleton, O. Kashala, L. ShulmanVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)70132-4
File:
PDF, 66 KB
english, 2010